Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Transcode Therapeutics Inc fell by 2.20m. Cash Flow from Financing totalled 15.91m or -- of revenues. In addition the company used 18.07m for operations while cash used for investing totalled 35.61k.
Cash flow per share | -5.53 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.182 |
---|---|
Tangible book value per share | 0.182 |
More ▼
Balance sheet in USDView more
Current ratio | 1.25 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼